Current Status of Diagnosis and Treatment of High-risk Resistant and Recurrent Gestational Trophoblastic Neoplasia
Gestational trophoblastic neoplasia (GTN) patients can be classified into low-risk and high-risk patients based on the International Federation of Gynecology and Obstetrics(FIGO) staging and scoring system. High-risk patients have a higher risk of resistance to single-agent chemotherapy and require...
Saved in:
Main Authors: | MAO Mingyi, JIANG Fang, XIANG Yang |
---|---|
Format: | Article |
Language: | zho |
Published: |
Editorial Office of Medical Journal of Peking Union Medical College Hospital
2024-04-01
|
Series: | Xiehe Yixue Zazhi |
Subjects: | |
Online Access: | https://xhyxzz.pumch.cn/article/doi/10.12290/xhyxzz.2024-0135 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
EMA/CO Combination Chemotheraphy in Gestational Trophoblastic Neoplasia: Update of Our Results
by: Tolga Taşçı, et al.
Published: (2015-08-01) -
Gestational trophoblastic disease: understanding the molecular mechanisms of placental tumours
by: Alina Nicheperovich, et al.
Published: (2025-01-01) -
Decoding the Genetics of Recurrent Molar Pregnancy
by: Sumita Mehta, et al.
Published: (2024-01-01) -
The regulatory role of placental extracellular vesicle on trophoblast and endothelial cell functions
by: Kunfeng Bai, et al.
Published: (2025-02-01) -
RETRACTED: Palmitic Acid Impedes Extravillous Trophoblast Activity by Increasing MRP1 Expression and Function
by: Yunali Ashar, et al.
Published: (2022-08-01)